Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
207.50    2.00 (0.97%)
Bid:
207.50
Ask:
208.50
Spread: 1.00 (0.482%)
Market Cap: £552.34m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Director/PDMR Shareholding

30 Oct 2024 10:23

RNS Number : 2441K
Costain Group PLC
30 October 2024
Β 

Β 

Costain Group PLC (the Company or Costain)

30 October 2024

Β 

Β 

EXERCISE OF NIL COST OPTIONS

Β 

(a) Total Beneficial Holding of Shares

Β 

Costain announces that, following the exercise of share awards granted under the Company's 2014 Share Deferral Plan (SDP) as detailed in section (b) below, Helen Willis, chief financial officer, held the number of ordinary shares of 1 pence each in the share capital of the Company (the "Shares") as set out in the table below:

Β 

Name of Director

Total beneficial holding of Shares held prior to the transactions detailed in section (b) below

Total beneficial holding of Shares held following the transactions detailed in section (b) below

Β 

Helen Willis

Β 

Β 

0

Β 

132,248

Β 

(b) Share Deferral Plan (SDP)

Β 

On 6 April 2022, awards were granted under the Costain Group PLC 2014 Share Deferral Plan to certain Directors and employees of the Company. The awards were granted in the form of options with a nil exercise price over a fixed number of Shares (the "Awards"). No consideration was paid for the grant of the Awards. The Awards vested on 6 April 2024 and became exercisable for a period of ten years from the date of grant.

Β 

On 29 October 2024, the Company was advised that Buck Trustees (Guernsey) Limited, as Trustee of the Costain Group Employee Trust, had undertaken the following transaction:

Β 

On 28 October 2024, Helen Willis exercised her Award to acquire the number of Shares as set out in the table below. Also as detailed below, Helen sold a number of Shares sufficient to satisfy her income tax and national insurance liability arising on exercise and then, in line with the Company's remuneration policy, Helen retained 50% and sold 50% of the remaining shares.

Β 

Name of

Director

Β 

Total number of Shares acquired on exercise of Awards (including Dividend Shares accrued at vesting)

Β 

Exercise Price

Number of Shares sold to satisfy Tax and National Insurance Liabilities, such Shares sold at a price per Share of 107.00 pence

Β 

Number of additional Shares sold at a price per Share of 106.75 pence

Number of Shares retained*

Helen Willis

499,052

Nil

234,555

132,249

132,248

Β 

* transferred to spouse, retaining the beneficial ownership of the shares.

Β 

Β 

Β 

Β 

Β 

Β 

The Notification of Dealing Form set out below is provided in accordance with the requirements of the Market Abuse Regulation.

Notification of Dealing Form

Β 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

a)

Name

HELEN MARGARET WILLIS

2.

Reason for the notification

a)

Position /status

CHIEF FINANCIAL OFFICER/ PDMR

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

COSTAIN GROUP PLC

b)

LEI code

213800PKIJBZ2EDTKC88

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Β 

ORDINARY SHARES OF 1 PENCE EACH

Β 

ISIN: GB00B64NSP76

b)

Nature of the transaction

(1)Β  EXERCISE OF NIL COST OPTIONS UNDER THE COMPANY'S 2014 SHARE DEFERRAL PLAN (2022 SDP GRANT)

(2) SALE OF SHARES TO SATISFY TAX AND NI LIABILITIES

c)

Price(s) and volume(s)

Price(s)

Volume(s)

(1)Β  Nil Cost

499,052

(2) Β£1.07

234,555

Β 

Β 

Β 

d)

Aggregated information

- Aggregated volume

Β 

Β 

Β 

- Price

Β 

Total number of Shares vested - 499,052

Β 

Number of Shares sold to cover Tax and NI - 234,555

Β 

Total price - Β£250,973.85

Β 

e)

Date of the transaction

(1)Β  28 OCTOBER 2024

(2) 28 OCTOBER 2024

Β 

f)

Place of the transaction

(1)Β  OUTSIDE A TRADING VENUE

(2)Β  OUTSIDE A TRADING VENUE

Β 

Β 

Β 

Notification of Dealing Form

Β 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

a)

Name

HELEN MARGARET WILLIS

2.

Reason for the notification

a)

Position /status

CHIEF FINANCIAL OFFICER/ PDMR

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

COSTAIN GROUP PLC

b)

LEI code

213800PKIJBZ2EDTKC88

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Β 

ORDINARY SHARES OF 1 PENCE EACH

Β 

ISIN: GB00B64NSP76

b)

Nature of the transaction

SALE OF SHARES

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Β£1.0675

132,249

Β 

Β 

Β 

d)

Aggregated information

- Aggregated volume

Β 

- Price

Β 

Total number of shares sold - 132,249

Β 

Total price - Β£141,175.81

Β 

e)

Date of the transaction

29 OCTOBER 2024

f)

Place of the transaction

LONDON STOCK EXCHANGE

Β 

Enquiries:

Β 

Investors and analysts

Paul Sharma, Costain

paul.sharma@costain.com

+44 (0)7867 501188

Β 

Financial media - Headland

costain@headlandconsultancy.com

Andy Rivett-Carnac

Charlie Twigg

+44 (0)7968 997365

+44 (0)7946 494568

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHFDEFSSELSEES
Date   Source Headline
25th Jun 202610:25 amRNSDirector/PDMR Shareholding
24th Jun 202610:30 amRNSTransaction in Own Shares
23rd Jun 202610:11 amRNSDirector/PDMR Shareholding
18th Jun 202611:46 amRNSDirector/PDMR Shareholding
18th Jun 20267:00 amRNS-RCostain wins West Winch Housing Road contract
17th Jun 202610:30 amRNSTransaction in Own Shares
10th Jun 20269:27 amRNSTransaction in Own Shares
9th Jun 20263:25 pmRNSHolding(s) in Company
9th Jun 20267:00 amRNSCostain wins place on £700m TfL framework
3rd Jun 202610:30 amRNSTransaction in Own Shares
1st Jun 202610:31 amRNSTotal Voting Rights
27th May 20269:34 amRNSTransaction in Own Shares
22nd May 20261:00 pmRNSDirector/PDMR Shareholding
20th May 20269:55 amRNSTransaction in Own Shares
18th May 20261:51 pmRNSAdditional Listing
18th May 20269:39 amRNSDirector Declaration
14th May 20264:28 pmRNSResult of AGM
14th May 20267:00 amRNSAGM Trading Update
13th May 20265:14 pmRNSHolding(s) in Company
13th May 202610:19 amRNSTransaction in Own Shares
12th May 20264:01 pmRNSHolding(s) in Company
6th May 20269:35 amRNSTransaction in Own Shares
5th May 20262:08 pmRNSDirector/PDMR Shareholding
1st May 20264:08 pmRNSScrip Dividend Reference Price - Replacement
1st May 20269:08 amRNSTotal Voting Rights
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
29th Apr 202610:14 amRNSTransaction in Own Shares
27th Apr 202612:27 pmRNSScrip Dividend Reference Price
22nd Apr 20265:06 pmRNSDirector/PDMR Shareholding
22nd Apr 202611:48 amRNSTransaction in Own Shares
21st Apr 20265:15 pmRNSHolding(s) in Company
16th Apr 20264:59 pmRNSHolding(s) in Company
15th Apr 20263:16 pmRNSTransaction in Own Shares
15th Apr 20263:05 pmRNSDirector/PDMR Shareholding
14th Apr 20263:29 pmRNSDirector Declaration
13th Apr 202611:20 amRNSDirector/PDMR Shareholding
8th Apr 202610:30 amRNSTransaction in Own Shares
2nd Apr 202611:19 amRNSAnnual Financial Report
1st Apr 202610:30 amRNSTransaction in Own Shares
1st Apr 20269:30 amRNSDirector/PDMR Shareholding
1st Apr 20268:59 amRNSTotal Voting Rights
27th Mar 20263:35 pmRNSAdditional Listing
25th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNS-RCostain Secures c.£45m Contract with Severn Trent
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:00 amRNSFinal Results
4th Mar 20268:27 amRNSDirectorate change
3rd Mar 202610:57 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.